Modulatory effects of curcumin on multi-drug resistance-associated protein 5 in pancreatic cancer cells

Cancer Chemotherapy and Pharmacology

Volumn 68, Issue 3, 2011, Pages 603-610

  Li, Yan ^a   Revalde, Jezrael L ^a   Reid, Glen ^a,b   Paxton, James W ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

5 Fluorouracil; Curcumin; Multi drug resistance associated protein 5; Pancreatic cancer

Indexed keywords

CURCUMIN; FLUOROURACIL; MONOCLONAL ANTIBODY; MULTIDRUG RESISTANCE PROTEIN 5; MULTIDRUG RESISTANCE PROTEIN 5 ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; BIOACCUMULATION; CANCER CELL; CANCER RESISTANCE; CELL ASSAY; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN HEK293; CELL STRAIN MIAPACA 2; CELL STRAIN PANC 1; CHEMOSENSITIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MULTIDRUG RESISTANCE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ANTICARCINOGENIC AGENTS; ANTIMETABOLITES, ANTINEOPLASTIC; CELL LINE, TUMOR; CELL SURVIVAL; CURCUMIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FLUORESCEINS; FLUORESCENT ANTIBODY TECHNIQUE; FLUORESCENT DYES; FLUOROURACIL; GENISTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PANCREATIC NEOPLASMS;

EID: 80053117135     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-010-1515-6     Document Type: Article

References (42)

1. A Sultana P Ghaneh D Cunningham N Starling JP Neoptolemos CT Smith 2008 Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison BMC Cancer 8 192 1471-2407-8-192[pii]10.1186/1471- 2407-8-192 18611273 10.1186/1471-2407-8-192
2. D Cunningham I Chau DD Stocken JW Valle D Smith W Steward PG Harper J Dunn C Tudur-Smith J West S Falk A Crellin F Adab J Thompson P Leonard J Ostrowski M Eatock W Scheithauer R Herrmann JP Neoptolemos 2009 Phase iii randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer J Clin Oncol 27 33 5513 5518 JCO.2009.24.2446[pii]10.1200/JCO.2009.24.2446 19858379 10.1200/JCO.2009.24.2446 1:CAS:528:DC%2BC3cXhtVWitrc%3D
3. P Borst RO Elferink 2002 Mammalian abc transporters in health and disease Annu Rev Biochem 71 537 592 10.1146/annurev.biochem.71.102301.093055102301. 093055[pii] 12045106 10.1146/annurev.biochem.71.102301.093055 1:CAS:528:DC%2BD38Xos1Clt74%3D
4. J Konig M Hartel AT Nies ME Martignoni J Guo MW Buchler H Friess D Keppler 2005 Expression and localization of human multidrug resistance protein (abcc) family members in pancreatic carcinoma Int J Cancer 115 3 359 367 10.1002/ijc.20831 15688370 10.1002/ijc.20831
5. G Szakacs JK Paterson JA Ludwig C Booth-Genthe MM Gottesman 2006 Targeting multidrug resistance in cancer Nat Rev Drug Discov 5 3 219 234 nrd1984[pii]10.1038/nrd1984 16518375 10.1038/nrd1984 1:CAS:528: DC%2BD28XhvFOlsr8%3D
6. W Hagmann R Jesnowski R Faissner C Guo JM Lohr 2009 Atp-binding cassette c transporters in human pancreatic carcinoma cell lines. Upregulation in 5-fluorouracil-resistant cells Pancreatology 9 1-2 136 144 000178884[pii]10. 1159/000178884 19077464 10.1159/000178884 1:CAS:528:DC%2BD1MXktFWjtb0%3D
7. W Hagmann R Jesnowski J Matthias Löhr 2010 Interdependence of gemcitabine treatment, transporter expression and resistance in human pancreatic carcinoma cells Neoplasma 12 9 740 747 10.1593/neo.10576 1:CAS:528: DC%2BC3cXhtFGmtrfL
8. T Oguri H Achiwa S Sato Y Bessho Y Takano M Miyazaki H Muramatsu H Maeda T Niimi R Ueda 2006 The determinants of sensitivity and acquired resistance to gemcitabine differ in non-small cell lung cancer: a role of abcc5 in gemcitabine sensitivity Mol Cancer Ther 5 7 1800 1806 5/7/1800[pii]10.1158/1535-7163.MCT- 06-0025 16891466 10.1158/1535-7163.MCT-06-0025 1:CAS:528:DC%2BD28XnslWksb0%3D
9. S Shukla CP Wu SV Ambudkar 2008 Development of inhibitors of atp-binding cassette drug transporters: present status and challenges Expert Opin Drug Metab Toxicol 4 2 205 223 10.1517/17425255.4.2.205 18248313 10.1517/17425255.4.2.205 1:CAS:528:DC%2BD1cXhsVSgurY%3D
10. W Chearwae S Shukla P Limtrakul SV Ambudkar 2006 Modulation of the function of the multidrug resistance-linked atp-binding cassette transporter abcg2 by the cancer chemopreventive agent curcumin Mol Cancer Ther 5 8 1995 2006 5/8/1995[pii]10.1158/1535-7163.MCT-06-0087 16928820 10.1158/1535-7163.MCT-06- 0087 1:CAS:528:DC%2BD28XosVansL8%3D
11. SZ Zhang XN Yang ME Morris 2004 Flavonoids are inhibitors of breast cancer resistance protein (abcg2)-mediated transport Mol Pharmacol 65 5 1208 1216 15102949 10.1124/mol.65.5.1208 1:CAS:528:DC%2BD2cXjsFKgtro%3D
12. CP Wu AM Calcagno SB Hladky SV Ambudkar MA Barrand 2005 Modulatory effects of plant phenols on human multidrug-resistance proteins 1, 4 and 5 (abcc1, 4 and 5) FEBS J 272 18 4725 4740 EJB4888[pii]10.1111/j.1742-4658.2005. 04888.x 16156793 10.1111/j.1742-4658.2005.04888.x 1:CAS:528:DC%2BD2MXhtVKru77F
13. P Limtrakul W Chearwae S Shukla C Phisalphong SV Ambudkar 2007 Modulation of function of three abc drug transporters, p-glycoprotein (abcb1), mitoxantrone resistance protein (abcg2) and multidrug resistance protein 1 (abcc1) by tetrahydrocurcumin, a major metabolite of curcumin Mol Cell Biochem 296 1-2 85 95 10.1007/s11010-006-9302-8 16960658 10.1007/s11010-006-9302-8 1:CAS:528:DC%2BD2sXjvFKis7o%3D
14. S Anuchapreeda P Leechanachai MM Smith SV Ambudkar PN Limtrakul 2002 Modulation of p-glycoprotein expression and function by curcumin in multidrug-resistant human kb cells Biochem Pharmacol 64 4 573 582 S0006295202012248[pii] 12167476 10.1016/S0006-2952(02)01224-8 1:CAS:528:DC%2BD38XmtVWls7g%3D
15. AB Kunnumakkara S Guha S Krishnan P Diagaradjane J Gelovani BB Aggarwal 2007 Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappab-regulated gene products Cancer Res 67 8 3853 3861 67/8/3853[pii]10.1158/0008-5472.CAN-06-4257 17440100 10.1158/0008-5472.CAN-06-4257 1:CAS:528:DC%2BD2sXkt1Kitb0%3D
16. BB Patel R Sengupta S Qazi H Vachhani Y Yu AK Rishi AP Majumdar 2008 Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating egfr and igf-1r Int J Cancer 122 2 267 273 10.1002/ijc.23097 17918158 10.1002/ijc.23097 1:CAS:528:DC%2BD2sXhsVOnsrrK
17. Bisht S, Mizuma M, Feldmann G, Ottenhof NA, Hong SM, Pramanik D, Chenna V, Karikari C, Sharma R, Goggins MG, Rudek MA, Ravi R, Maitra A (2010) Systemic administration of polymeric nanoparticle-encapsulated curcumin (nanocurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer. Mol Cancer Ther 9(8):2255-2264. doi: 1535-7163.MCT-10-0172
18. N Dhillon BB Aggarwal RA Newman RA Wolff AB Kunnumakkara JL Abbruzzese CS Ng V Badmaev R Kurzrock 2008 Phase ii trial of curcumin in patients with advanced pancreatic cancer Clin Cancer Res 14 14 4491 4499 14/14/4491[pii]10. 1158/1078-0432.CCR-08-0024 18628464 10.1158/1078-0432.CCR-08-0024 1:CAS:528:DC%2BD1cXosFGitLw%3D
19. S Pratt RL Shepard RA Kandasamy PA Johnston W Perry 3rd AH Dantzig 2005 The multidrug resistance protein 5 (abcc5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites Mol Cancer Ther 4 5 855 863 4/5/855[pii]10.1158/1535-7163.MCT-04-0291 15897250 10.1158/1535-7163.MCT-04-0291 1:CAS:528:DC%2BD2MXktFyktL4%3D
20. T Hirohashi T Terasaki M Shigetoshi Y Sugiyama 1997 In vivo and in vitro evidence for nonrestricted transport of 2′, 7′-bis(2-carboxyethyl)- 5(6)-carboxyfluorescein tetraacetoxymethyl ester at the blood-brain barrier J Pharmacol Exp Ther 280 2 813 819 9023295 1:CAS:528:DyaK2sXivVWku7o%3D
21. MA McAleer MA Breen NL White N Matthews 1999 Pabc11 (also known as moat-c and mrp5), a member of the abc family of proteins, has anion transporter activity but does not confer multidrug resistance when overexpressed in human embryonic kidney 293 cells J Bio Chem 274 33 23541 23548 10.1074/jbc.274.33. 23541 1:CAS:528:DyaK1MXltlKmsrw%3D
22. MW Saif A Choma SJ Salamone E Chu 2009 Pharmacokinetically guided dose adjustment of 5-fluorouracil: a rational approach to improving therapeutic outcomes J Natl Cancer Inst 101 22 1543 1552 10.1093/jnci/djp328 19841331 10.1093/jnci/djp328 1:CAS:528:DC%2BD1MXhsVKls7vN
23. GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group PX K Oba T Burzykowski S Michiels Y Ohashi JP Pignon P Rougier J Sakamoto D Sargent M Sasako E Van Cutsem M Buyse 2010 Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis JAMA 303 17 1729 1737 10.1001/jama.2010.534 20442389 10.1001/jama.2010.534
24. J Wijnholds CAAM Mol L van Deemter M de Haas GL Scheffer F Baas JH Beijnen RJ Scheper S Hatse E De Clercq J Balzarini P Borst 2000 Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs Proc Natl Acad Sci U S A 97 13 7476 7481 10840050 10.1073/pnas.120159197 1:CAS:528:DC%2BD3cXksVKhs78%3D
25. PR Wielinga G Reid EE Challa I van der Heijden L van Deemter M de Haas C Mol AJ Kuil E Groeneveld JD Schuetz C Brouwer RA De Abreu J Wijnholds JH Beijnen P Borst 2002 Thiopurine metabolism and identification of the thiopurine metabolites transported by mrp4 and mrp5 overexpressed in human embryonic kidney cells Mol Pharmacol 62 6 1321 1331 12435799 10.1124/mol.62.6.1321 1:CAS:528:DC%2BD38XptVyls7w%3D
26. P Wielinga JH Hooijberg S Gunnarsdottir I Kathmann G Reid N Zelcer K van der Born M de Haas I van der Heijden G Kaspers J Wijnholds G Jansen G Peters P Borst 2005 The human multidrug resistance protein mrp5 transports folates and can mediate cellular resistance against antifolates Cancer Res 65 10 4425 4430 65/10/4425[pii]10.1158/0008-5472.CAN-04-2810 15899835 10.1158/0008-5472.CAN-04- 2810 1:CAS:528:DC%2BD2MXktlSmtLc%3D
27. G Reid P Wielinga N Zelcer M De Haas L Van Deemter J Wijnholds J Balzarini P Borst 2003 Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins mrp4 and mrp5 Mol Pharmacol 63 5 1094 1103 12695538 10.1124/mol.63.5.1094 1:CAS:528:DC%2BD3sXjt12lu7Y%3D
28. M Solazzo O Fantappie M D'Amico C Sassoli A Tani G Cipriani C Bogani L Formigli R Mazzanti 2009 Mitochondrial expression and functional activity of breast cancer resistance protein in different multiple drug-resistant cell lines Cancer Res 69 18 7235 7242 0008-5472.CAN-08-4315[pii]10.1158/0008-5472.CAN-08- 4315 19706772 10.1158/0008-5472.CAN-08-4315 1:CAS:528:DC%2BD1MXhtFaku73I
29. E Jaruga A Sokal S Chrul G Bartosz 1998 Apoptosis-independent alterations in membrane dynamics induced by curcumin Exp Cell Res 245 2 303 312 S0014-4827(98)94225-2[pii]10.1006/excr.1998.4225 9851871 10.1006/excr.1998.4225 1:CAS:528:DyaK1cXotVWqsLg%3D
30. Y Guo E Kotova ZS Chen K Lee E Hopper-Borge MG Belinsky GD Kruh 2003 Mrp8, atp-binding cassette c11 (abcc11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2′, 3′-dideoxycytidine and 9′-(2′-phosphonylmethoxyethyl)adenine J Bio Chem 278 32 29509 29514 10.1074/jbc.M304059200M304059200[pii] 10.1074/jbc.M304059200 1:CAS:528:DC%2BD3sXlvFOgu74%3D
31. L Zhao Y Pan Y Gang H Wang H Jin J Tie L Xia Y Zhang L He L Yao T Qiao T Li Z Liu D Fan 2009 Identification of gas1 as an epirubicin resistance-related gene in human gastric cancer cells with a partially randomized small interfering rna library J Biol Chem 284 39 26273 26285 M109.028068[pii]10.1074/jbc.M109. 028068 19638344 10.1074/jbc.M109.028068 1:CAS:528:DC%2BD1MXhtFCgs7%2FP
32. AC Bharti N Donato S Singh BB Aggarwal 2003 Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa b and ikappabalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis Blood 101 3 1053 1062 10.1182/blood-2002-05-13202002-05-1320[pii] 12393461 10.1182/blood-2002-05-1320 1:CAS:528:DC%2BD3sXptVCisg%3D%3D
33. W Wang JL Abbruzzese DB Evans L Larry KR Cleary PJ Chiao 1999 The nuclear factor-kappa b rela transcription factor is constitutively activated in human pancreatic adenocarcinoma cells Clin Cancer Res 5 1 119 127 9918209 1:CAS:528:DyaK1MXhtVShtLY%3D
34. MT Kuo Z Liu Y Wei YC Lin-Lee S Tatebe GB Mills H Unate 2002 Induction of human mdr1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate nf-kappab signaling Oncogene 21 13 1945 1954 11960367 10.1038/sj.onc.1205117 1:CAS:528: DC%2BD38XivVeltbs%3D
35. J Sims-Mourtada JG Izzo J Ajani KS Chao 2007 Sonic hedgehog promotes multiple drug resistance by regulation of drug transport Oncogene 26 38 5674 5679 1210356[pii]10.1038/sj.onc.1210356 17353904 10.1038/sj.onc.1210356 1:CAS:528:DC%2BD2sXptFemtbc%3D
36. M Labbozzetta M Notarbartolo P Poma A Maurici L Inguglia P Marchetti M Rizzi R Baruchello D Simoni N D'Alessandro 2009 Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer Ann N Y Acad Sci 1155 278 283 NYAS03699[pii]10.1111/j.1749-6632.2009.03699.x 19250217 10.1111/j.1749-6632.2009.03699.x 1:CAS:528:DC%2BD1MXktFKlt7g%3D
37. P Anand AB Kunnumakkara RA Newman BB Aggarwal 2007 Bioavailability of curcumin: Problems and promises Mol Pharm 4 6 807 818 10.1021/mp700113r 17999464 10.1021/mp700113r 1:CAS:528:DC%2BD2sXht12gsrnF
38. S Bisht G Feldmann S Soni R Ravi C Karikar A Maitra 2007 Polymeric nanoparticle-encapsulated curcumin ("Nanocurcumin"): a novel strategy for human cancer therapy J Nanobiotechnology 5 3 1477-3155-5-3[pii]10.1186/1477- 3155-5-3 17439648 10.1186/1477-3155-5-3
39. C Chen TD Johnston H Jeon R Gedaly PP McHugh TG Burke D Ranjan 2009 An in vitro study of liposomal curcumin: Stability, toxicity and biological activity in human lymphocytes and epstein-barr virus-transformed human b-cells Int J Pharm 366 1-2 133 139 S0378-5173(08)00620-0[pii]10.1016/j.ijpharm.2008.09.009 18840516 10.1016/j.ijpharm.2008.09.009 1:CAS:528:DC%2BD1cXhsFCjurvM
40. J Cui B Yu Y Zhao W Zhu H Li H Lou G Zhai 2009 Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems Int J Pharm 371 1-2 148 155 S0378-5173(08)00824-7[pii]10.1016/j.ijpharm.2008.12.009 19124065 10.1016/j.ijpharm.2008.12.009 1:CAS:528:DC%2BD1MXjslWktbg%3D
41. JP Neoptolemos DD Stocken C Bassi P Ghaneh D Cunningham D Goldstein R Padbury MJ Moore S Gallinger C Mariette MN Wente JR Izbicki H Friess MM Lerch C Dervenis A Olah G Butturini R Doi PA Lind D Smith JW Valle DH Palmer JA Buckels J Thompson CJ McKay CL Rawcliffe MW Buchler For the European Study Group for Pancreatic C 2010 Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial JAMA 304 10 1073 1081 10.1001/jama.2010.1275 20823433 10.1001/jama.2010.1275 1:CAS:528:DC%2BC3cXhtFequ7nE
42. Fang J, Nakamura H, Maeda H (2010) The epr effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev. doi:S0169-409X(10)00090-6 [pii] 10.1016/j.addr.2010.04.009